CLINICAL TRIALS PROFILE FOR METHACHOLINE CHLORIDE
✉ Email this page to a colleague
All Clinical Trials for METHACHOLINE CHLORIDE
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT00673621 ↗ | A Study Designed to Determine if the Pharmacokinetic Disposition of Inhaled Insulin Exposure is the Same for Asthmatics and Non-asthmatics | Completed | Mannkind Corporation | Phase 1 | 2008-05-01 | This study will compare the rate and extent of absorption of TI Inhalation Powder in subjects with asthma and subjects with normal lung function. 24 eligible subjects will be enrolled into the treatment phase of the trial. |
NCT01699594 ↗ | Change in Airway Responsiveness After Allergen Exposure | Completed | University of Saskatchewan | N/A | 2012-10-01 | Exposure to allergens changes the way the airway responds to some stimuli (methacholine). The investigators will look at whether or not exposure to allergens changes the way the airway responds to a different stimuli (mannitol) and compare that with the known stimuli (methacholine). |
NCT01907334 ↗ | Dose-Response of Salmeterol in Children | Completed | Teva Branded Pharmaceutical Products R&D, Inc. | Phase 4 | 2013-08-01 | To examine whether a breathing test (methacholine challenge using impulse oscillometry) can be used to tell the difference between two different doses of an inhaled drug, salmeterol, delivered by Advair in children with asthma |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for METHACHOLINE CHLORIDE
Condition Name
Clinical Trial Locations for METHACHOLINE CHLORIDE
Trials by Country
Clinical Trial Progress for METHACHOLINE CHLORIDE
Clinical Trial Phase
Clinical Trial Sponsors for METHACHOLINE CHLORIDE
Sponsor Name